Resveratrol (3,5,4'-trihydroxystilbene) protects pregnant mother and fetus from the immunotoxic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin

Molecular Nutrition and Food Research

Volumn 55, Issue 2, 2011, Pages 209-219

  Singh, Narendra P ^a   Singh, Ugra S ^a   Nagarkatti, Mitzi ^a   Nagarkatti, Prakash S ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

2, 3, 7, 8 Tetrachlorodibenzo p dioxin; Aryl hydrocarbon receptor; Fetus; Immunotoxicity; Resveratrol

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1A1; PROTECTIVE AGENT; RESVERATROL; STILBENE DERIVATIVE;

ANIMAL; APOPTOSIS; ARTICLE; ATROPHY; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; DRUG ANTAGONISM; DRUG EFFECT; ENVIRONMENTAL EXPOSURE; FEMALE; FETUS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE; PATHOLOGY; POLLUTANT; PREGNANCY; T LYMPHOCYTE SUBPOPULATION; THYMUS;

ANIMALS; APOPTOSIS; ATROPHY; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOCHROME P-450 CYP1A1; ENVIRONMENTAL POLLUTANTS; FEMALE; FETUS; GENE EXPRESSION REGULATION; MATERNAL EXPOSURE; MICE; MICE, INBRED C57BL; PREGNANCY; PROTECTIVE AGENTS; RECEPTORS, ARYL HYDROCARBON; STILBENES; T-LYMPHOCYTE SUBSETS; TETRACHLORODIBENZODIOXIN; THYMUS GLAND;

MUS;

EID: 79551571722     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201000206     Document Type: Article

References (42)

1. Barker, D. J., Eriksson, J. G., Forsen, T., Osmond, C., Fetal origins of adult disease: strength of effects and biological basis. Int. J. Epidemiol. 2002; 31, 1235-1239.
2. Phillips, D. I., External influences on the fetus and their long-term consequences. Lupus 2006, 15, 794-800.
3. Camacho, I. A., Nagarkatti, M., Nagarkatti, P. S., Effect of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) on maternal immune response during pregnancy. Arch. Toxicol. 2004, 78, 290-300.
4. Mustafa, A., Holladay, S. D., Goff, M., Witonsky, S. et al., Developmental exposure to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin alters postnatal T cell phenotypes and T cell function and exacerbates autoimmune lupus in 24-week-old SNF1 mice. Birth Defects Res. A Clin. Mol. Teratol. 2009, 85, 828-836.
5. Marlowe, J. L., Puga, A., Aryl hydrocarbon receptor, cell cycle regulation, toxicity, and tumorigenesis. J. Cell. Biochem. 2005, 96, 1174-1184.
6. de la Lastra, C. A., Villegas, I., Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications. Mol. Nutr. Food Res. 2005, 49, 405-430.
7. Donnelly, L. E., Newton, R., Kennedy, G. E., Fenwick, P. S. et al., Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004, 287, L774-L783.
8. Liu, H. S., Pan, C. E., Yang, W., Liu, X. M., Antitumor and immunomodulatory activity of resveratrol on experimentally implanted tumor of H22 in Balb/c mice. World J. Gastroenterol. 2003, 9, 1474-1476.
9. Falchetti, R., Fuggetta, M. P., Lanzilli, G., Tricarico, M., Ravagnan, G., Effects of resveratrol on human immune cell function. Life Sci. 2001, 70, 81-96.
10. Fremont, L., Biological effects of resveratrol. Life Sci. 2000, 66, 663-673.
11. Mollerup, S., Ovrebo, S., Haugen, A., Lung carcinogenesis: resveratrol modulates the expression of genes involved in the metabolism of PAH in human bronchial epithelial cells. Int. J. Cancer 2001, 92, 18-25.
12. Singh, S. U., Casper, R. F., Fritz, P. C., Sukhu, B. et al., Inhibition of dioxin effects on bone formation in vitro by a newly described aryl hydrocarbon receptor antagonist, resveratrol. J. Endocrinol. 2000, 167, 183-195.
13. Casper, R. F., Quesne, M., Rogers, I. M., Shirota, T. et al., Resveratrol has antagonist activity on the aryl hydrocarbon receptor: implications for prevention of dioxin toxicity. Mol. Pharmacol. 1999, 56, 784-790.
14. Ciolino, H. P., Daschner, P. J., Yeh, G. C., Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor. Cancer Res. 1998, 58, 5707-5712.
15. Ishida, T., Takeda, T., Koga, T., Yahata, M. et al., Attenuation of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin toxicity by resveratrol: a comparative study with different routes of administration. Biol. Pharm. Bull. 2009, 32, 876-881.
16. Camacho, I. A., Nagarkatti, M., Nagarkatti, P. S., Evidence for induction of apoptosis in T cells from murine fetal thymus following perinatal exposure to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol. Sci. 2004, 78, 96-106.
17. Singh, N. P., Hegde, V., Hofseth, L. J., Nagarkatti, M., Nagarkatti, P., Resveratrol (trans-3, 5, 4'-trihydroxystilbene) ameliorates experimental allergic encephalomyelitis (EAE) primarily via induction of apoptosis in T cells involving activation of AhR and ER. Mol. Pharmacol. 2007, 72, 1508-1521.
18. Kamath, A. B., Nagarkatti, P. S., Nagarkatti, M., Characterization of phenotypic alterations induced by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin on thymocytes in vivo and its effect on apoptosis. Toxicol. Appl. Pharmacol. 1998, 150, 117-124.
19. Singh, N. P., Nagarkatti, M., Nagarkatti, P., Primary peripheral T cells become susceptible to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin-mediated apoptosis in vitro upon activation and in the presence of dendritic cells. Mol. Pharmacol. 2008, 73, 1722-1735.
20. Camacho, I. A., Singh, N., Hegde, V. L., Nagarkatti, M., Nagarkatti, P. S., Treatment of mice with 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin leads to aryl hydrocarbon receptor-dependent nuclear translocation of NF-kappaB and expression of fas ligand in thymic stromal cells and consequent apoptosis in T cells. J. Immunol. 2005, 175, 90-103.
21. Kamath, A. B., Xu, H., Nagarkatti, P. S., Nagarkatti, M., Evidence for the induction of apoptosis in thymocytes by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin in vivo. Toxicol. Appl. Pharmacol. 1997, 142, 367-377.
22. Camacho, I. A., Hassuneh, M. R., Nagarkatti, M., Nagarkatti, P. S., Enhanced activation-induced cell death as a mechanism of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD)-induced immunotoxicity in peripheral T cells. Toxicology 2001, 165, 51-63.
23. Camacho, I. A., Nagarkatti, M., Nagarkatti, P. S., 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin (TCDD) induces Fas-dependent activation-induced cell death in superantigen-primed T cells. Arch. Toxicol. 2002, 76, 570-580.
24. Nebert, D. W., Puga, A., Vasiliou, V., Role of the Ah receptor and the dioxin-inducible [Ah] gene battery in toxicity, cancer, and signal transduction. Ann. NY Acad. Sci. 1993, 685, 624-640.
25. Tian, Y., Ke, S., Denison, M. S., Rabson, A. B., Gallo, M. A., Ah receptor and NF-kappaB interactions, a potential mechanism for dioxin toxicity. J. Biol. Chem. 1999, 274, 510-515.
26. Zeytun, A., McKallip, R. J., Fisher, M., Camacho, I. et al., Analysis of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin-induced gene expression profile in vivo using pathway-specific cDNA arrays. Toxicology 2002, 178, 241-260.
27. Dietert, R. R., Piepenbrink, M. S., The managed immune system: protecting the womb to delay the tomb. Hum. Exp. Toxicol. 2008, 27, 129-134.
28. Giusti, R. M., Iwamoto, K., Hatch, E. E., Diethylstilbestrol revisited: a review of the long-term health effects. Ann. Intern. Med. 1995, 122, 778-788.
29. Brown, N., Nagarkatti, M., Nagarkatti, P. S., Diethylstilbestrol alters positive and negative selection of T cells in the thymus and modulates T-cell repertoire in the periphery. Toxicol. Appl. Pharmacol. 2006, 212, 119-126.
30. Fisher, M. T., Nagarkatti, M., Nagarkatti, P. S., 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin enhances negative selection of T cells in the thymus but allows autoreactive T cells to escape deletion and migrate to the periphery. Mol. Pharmacol. 2005, 67, 327-335.
31. Singh, N. P., Nagarkatti, M., Nagarkatti, P. S., Role of dioxin response element and nuclear factor-kappaB motifs in 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin-mediated regulation of Fas and Fas ligand expression. Mol. Pharmacol. 2007, 71, 145-157.
32. Chang, T. K., Chen, J., Lee, W. B., Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: evidence for mechanism-based inactivation of CYP1A2. J. Pharmacol. Exp. Ther. 2001, 299, 874-882.
33. Revel, A., Raanani, H., Younglai, E., Xu, J. et al., Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo[a]pyrene. J. Appl. Toxicol. 2003, 23, 255-261.
34. Chen, G., Bunce, N. J., Interaction between halogenated aromatic compounds in the Ah receptor signal transduction pathway. Environ. Toxicol. 2004, 19, 480-489.
35. Wilhelmsson, A., Whitelaw, M. L., Gustafsson, J. A., Poellinger, L., Agonistic and antagonistic effects of alpha-naphthoflavone on dioxin receptor function. Role of the basic region helix-loop-helix dioxin receptor partner factor Arnt. J. Biol. Chem. 1994, 269, 19028-19033.
36. Jang, J. Y., Park, D., Shin, S., Jeon, J. H. et al., Antiteratogenic effect of resveratrol in mice exposed in utero to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. Eur. J. Pharmacol. 2008, 591, 280-283.
37. Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E., Jr., Walle, U. K., High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab. Dispos. 2004, 32, 1377-1382.
38. Wenzel, E., Soldo, T., Erbersdobler, H., Somoza, V., Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats. Mol. Nutr. Food Res. 2005, 49, 482-494.
39. Wenzel, E., Somoza, V., Metabolism and bioavailability of trans-resveratrol. Mol. Nutr. Food Res. 2005, 49, 472-481.
40. Yu, C., Shin, Y. G., Chow, A., Li, Y. et al., van Breemen RB: human, rat, and mouse metabolism of resveratrol. Pharm. Res. 2002, 19, 1907-1914.
41. Singh, U. P., Singh, N. P., Singh, B., Hofseth, L. J. et al., Resveratrol (trans-3, 5, 4'-trihydroxystilbene) induces silent mating type information regulation-1 and down-regulates nuclear transcription factor-kappaB activation to abrogate dextran sulfate sodium-induced colitis. J. Pharmacol. Exp. Ther. 2010, 332, 829-839.
42. Bhat, K. P., Lantvit, D., Christov, K., Mehta, R. G. et al., Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models. Cancer Res 2001, 61, 7456-7463.